Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy.
Yang C, Geng H, Yang X, Ji S, Liu Z, Feng H, Li Q, Zhang T, Zhang S, Ma X, Zhu C, Xu N, Xia Y, Li Y, Wang H, Yu C, Du S, Miao B, Xu L, Wang H, Cao Y, Li B, Zhu L, Tang X, Zhang H, Zhu C, Huang Z, Leng C, Hu H, Chen X, Yuan S, Jin G, Bernards R, Sun C, Zheng Q, Qin W, Gao Q, Wang C.
Yang C, et al. Among authors: yang x.
Cancer Cell. 2024 Oct 29:S1535-6108(24)00396-9. doi: 10.1016/j.ccell.2024.10.008. Online ahead of print.
Cancer Cell. 2024.
PMID: 39515328